Differential effects of UCHL1 modulation on alpha-synuclein in PD-like models of alpha-synucleinopathy.
about
Exome sequencing reveals new causal mutations in children with epileptic encephalopathiesCatecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disordersAutophagy and neurodegenerationOxidative stress, mitochondrial damage and neurodegenerative diseasesThe ubiquitin C-terminal hydrolase L1 (UCH-L1) C terminus plays a key role in protein stability, but its farnesylation is not required for membrane association in primary neurons.Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.Inhibition of spinal UCHL1 attenuates pain facilitation in a cancer-induced bone pain model by inhibiting ubiquitin and glial activation.Ubiquitin pathways in neurodegenerative disease.Proteomic Analysis After Status Epilepticus Identifies UCHL1 as Protective Against Hippocampal Injury.mTOR Signaling in Parkinson's Disease.Inhibition of UCH-L1 in oligodendroglial cells results in microtubule stabilization and prevents α-synuclein aggregate formation by activating the autophagic pathway: implications for multiple system atrophy.In Situ Peroxidase Labeling and Mass-Spectrometry Connects Alpha-Synuclein Directly to Endocytic Trafficking and mRNA Metabolism in Neurons.UCH-L1 Expressed by Podocytes: a Potentially Therapeutic Target for Lupus Nephritis?The extent of neurodegeneration and neuroprotection in two chemical in vitro models related to Parkinson's disease is critically dependent on cell culture conditions.NH2-truncated human tau induces deregulated mitophagy in neurons by aberrant recruitment of Parkin and UCHL-1: implications in Alzheimer's disease.The Neuroprotective Role of Protein Quality Control in Halting the Development of Alpha-Synuclein Pathology.Zebrafish brain proteomics reveals central proteins involved in neurodegeneration.Let's make microglia great again in neurodegenerative disorders.cPKCγ-mediated down-regulation of UCHL1 alleviates ischaemic neuronal injuries by decreasing autophagy via ERK-mTOR pathway.Downregulation of miR-181b in mouse brain following ischemic stroke induces neuroprotection against ischemic injury through targeting heat shock protein A5 and ubiquitin carboxyl-terminal hydrolase isozyme L1.Boosting chaperone-mediated autophagy in vivo mitigates α-synuclein-induced neurodegeneration.3,4-Dihydroxyphenylacetaldehyde-Induced Protein Modifications and Their Mitigation by N-Acetylcysteine.
P2860
Q24604206-C9A2A2EC-2940-49A1-B0C3-2787EFF243B0Q26826093-6ED1CB6A-244A-4079-94C0-5585707E1D24Q26991692-5C432EBA-0D5A-41D7-AC0D-B41CFCC98B8CQ34094532-2AADC773-D987-4208-87A6-B13DD3C5A091Q34774553-414A6113-76F1-4C72-9A32-8B14A3D8FCC6Q35152946-2A56DC34-9955-4436-8B82-72EEC4FB21DAQ37144061-679A480F-C47F-4002-9C4C-65094918A6B7Q38234883-DC8C0859-3AB9-4B3D-9B9F-2EFB50C646D7Q38843289-870DC582-CE26-4C01-8E08-04F2D36C65FFQ38855225-76C5736A-6202-46CB-A0D5-B33B191460C1Q38872092-FD538BC1-3859-4649-8D2D-4E99A46066C6Q38993636-8B3A4D22-0BE3-43B4-9F31-965AAAF75F9FQ39100146-2D4E309B-EECC-451C-AAD0-608386063A9CQ39212503-FA4B63BB-FD7F-45ED-BA94-A47C6C30794AQ41427586-103089E3-1297-45F4-A658-6EC7B883E9A6Q42288817-13604691-F1E4-4DB7-81F3-3DF75D56FAE2Q44085138-716018F3-F0C2-4770-ABD2-F7D4AC690BBAQ46926746-E0CD91D3-1FEA-4975-898A-F246B63045DBQ47130601-C85E9FF7-DBF4-429E-8936-D2888ED20A19Q47895437-9661624F-702A-4581-A150-9065F645FDEFQ50479107-12FE17D1-5BDB-40B4-99AE-BEDC148DF564Q55361950-E9D6372A-7267-44A5-9C3A-47FC39D522A0
P2860
Differential effects of UCHL1 modulation on alpha-synuclein in PD-like models of alpha-synucleinopathy.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Differential effects of UCHL1 ...... dels of alpha-synucleinopathy.
@ast
Differential effects of UCHL1 ...... dels of alpha-synucleinopathy.
@en
Differential effects of UCHL1 ...... dels of alpha-synucleinopathy.
@nl
type
label
Differential effects of UCHL1 ...... dels of alpha-synucleinopathy.
@ast
Differential effects of UCHL1 ...... dels of alpha-synucleinopathy.
@en
Differential effects of UCHL1 ...... dels of alpha-synucleinopathy.
@nl
prefLabel
Differential effects of UCHL1 ...... dels of alpha-synucleinopathy.
@ast
Differential effects of UCHL1 ...... dels of alpha-synucleinopathy.
@en
Differential effects of UCHL1 ...... dels of alpha-synucleinopathy.
@nl
P2093
P2860
P50
P1433
P1476
Differential effects of UCHL1 ...... dels of alpha-synucleinopathy.
@en
P2093
Anna E Cartier
Brian Spencer
Christina Patrick
Gentry N Patrick
Kori Ann Kosberg
Lawrence Fourgeaud
Priya Kanayson
Ruben A Vazquez-Roque
P2860
P304
P356
10.1371/JOURNAL.PONE.0034713
P407
P577
2012-04-13T00:00:00Z